Cellectis Stock

Cellectis Employees 2024

Cellectis Employees

340

Ticker

ALCLS.PA

ISIN

FR0010425595

WKN

A0MKPR

In 2024, Cellectis employed 340 people, a 0% change from the 340 number of employees in the previous year.

Cellectis Aktienanalyse

What does Cellectis do?

Cellectis SA is an emerging biotechnology company focused on developing innovative therapies for cancer and other serious diseases. It was founded in 1999 by a French scientist named André Choulika and is headquartered in Paris, France. Cellectis' main business is the development of CAR-T cell therapies, which involve reprogramming immune cells to target specific types of cancer. This method specifically targets cancer cells while leaving healthy cells unaffected, offering a more precise and less invasive alternative to traditional cancer treatments. Cellectis' business model is centered around developing tailored cancer treatments for individual patients using its Cellectis System, a combination of genomic and cellular technologies. The company also has subsidiaries and joint ventures focusing on different segments of the biopharmaceutical market, such as Calyxt, which specializes in genetic modification of crops, and Ectycell, which focuses on developing cell therapies for rare blood diseases. Cellectis offers a range of products and services focused on cancer drug development, including cell therapies, genetic testing, clinical trials, and consulting services. Its products and services are tailored to the individual needs of patients and aim to revolutionize cancer treatment through advanced technology and innovative approaches. In summary, Cellectis is an innovative biotechnology company successfully focusing on developing tailored cancer therapies. With its wide range of products and services catering to patient needs, and with advancements in cancer therapy, Cellectis is well positioned to become a key player in the biopharmaceutical industry. Cellectis ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Cellectis's Employee Base

Cellectis's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Cellectis's operational capacity and future potential.

Year-to-Year Comparison

Assessing Cellectis's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Cellectis's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Cellectis’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Cellectis stock

How many employees does Cellectis have this year?

Cellectis has 340 undefined employees this year.

How many employees did Cellectis have compared to the previous year?

Compared to the previous year, Cellectis had 0% more employees.

What impact did the number of employees have on the company Cellectis?

The number of employees has a direct impact on the efficiency and productivity of Cellectis. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Cellectis?

The number of employees can also have an impact on investors of Cellectis, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Cellectis affect the company?

An increase in equity of Cellectis can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Cellectis's equity affect the company?

A reduction in equity of Cellectis can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Cellectis?

Some factors that can influence the equity of Cellectis include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Cellectis so important for investors?

The equity of Cellectis is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Cellectis influence the company?

The number of employees at Cellectis can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Cellectis evolved in recent years?

In recent years, the number of employees at Cellectis has changed by 0.

How many employees does Cellectis currently have?

Cellectis currently has 340 undefined employees.

Why is the number of employees important for investors of Cellectis?

The number of employees is important for investors of Cellectis as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Cellectis take to change the number of employees?

To change the number of employees, Cellectis can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Cellectis pay?

Over the past 12 months, Cellectis paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Cellectis is expected to pay a dividend of 0 USD.

What is the dividend yield of Cellectis?

The current dividend yield of Cellectis is .

When does Cellectis pay dividends?

Cellectis pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Cellectis?

Cellectis paid dividends every year for the past 0 years.

What is the dividend of Cellectis?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Cellectis located?

Cellectis is assigned to the 'Health' sector.

Wann musste ich die Aktien von Cellectis kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Cellectis from 7/31/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/31/2024.

When did Cellectis pay the last dividend?

The last dividend was paid out on 7/31/2024.

What was the dividend of Cellectis in the year 2023?

In the year 2023, Cellectis distributed 0 USD as dividends.

In which currency does Cellectis pay out the dividend?

The dividends of Cellectis are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Cellectis stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Cellectis

Our stock analysis for Cellectis Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cellectis Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.